一家主要Korro Bio股东在3月10日购买了2.3M美元股票, A major Korro Bio shareholder bought $2.3M in stock on March 10, boosting their stake by nearly 19%, despite the company's poor quarterly results.

2026年3月10日, Korro Bio(KRRO)的主要股东购买了207 100股,每股11.11美元,耗资约230万美元,股份增加18.99%,达到130万股。 On March 10, 2026, a major shareholder of Korro Bio (KRRO) purchased 207,100 shares at $11.11 each, spending about $2.3 million and increasing their stake by 18.99% to 1.3 million shares. 这一交易在SEC档案中披露,原因是该公司报告,每季度收入129万美元,每股损失5.32美元,比预期的要差得多。 The transaction, disclosed in an SEC filing, occurred as the company reported a quarterly loss of $5.32 per share on $1.29 million in revenue, significantly worse than expected. 尽管财政结果疲软,但内幕人士购买了显示信心的信号。 Despite weak financial results, the insider buy signaled confidence. 股票于3月13日以11.50美元关闭,减少了26美元,市场上限为1.0833亿美元,P/E比率为负数。 The stock closed at $11.50 on March 13, down $0.26, with a market cap of $108.33 million and a negative P/E ratio. 分析员持有“坚持”共识评级,平均目标是50.38美元。 Analysts hold a "Hold" consensus rating with a $50.38 average target.